We are live on ! Find out more
IMUX icon

Immunic
IMUX

58 hedge funds and large institutions have $28.3M invested in Immunic in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,064% more call options, than puts

Call options by funds: $256K | Put options by funds: $22K

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.06% less ownership

Funds ownership: 4.33% → 4.26% (-0.06%)

2% less funds holding

Funds holding: 59 → 58 (-1)

25% less capital invested

Capital invested by funds: $37.6M → $28.3M (-$9.38M)

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
9
Closed
9
Calls
$256K
Puts
$22K
Net Calls
+$234K
Net Calls Change
-$293K

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$3.21M
2
Millennium Management
Millennium Management
New York
+$2.12M
3
LCM
Laurion Capital Management
New York
+$1.47M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$495K
5
UBS Group
UBS Group
Switzerland
+$365K

Top Sellers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
-$1.39M
2
Morgan Stanley
Morgan Stanley
New York
-$741K
3
Renaissance Technologies
Renaissance Technologies
New York
-$345K
4
Citadel Advisors
Citadel Advisors
Florida
-$197K
5
IC
Ikarian Capital
Texas
-$175K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$69.7K -$80.8K -11,028 -46%
SWA
27
Strategies Wealth Advisors
Michigan
$53.4K – – –
HWM
28
HB Wealth Management
Georgia
$48.8K – – –
Two Sigma Investments
29
Two Sigma Investments
New York
$40.7K +$12.8K +1,751 +30%
LPL Financial
30
LPL Financial
California
$31K +$3.66K +500 +9%
BCM
31
Bridgeway Capital Management
Texas
$21.3K -$54.9K -7,500 -65%
Creative Planning
32
Creative Planning
Kansas
$18.7K – – –
MG
33
Marex Group
$17.5K +$7.47K +1,020 +45%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$16.3K – – –
Charles Schwab
35
Charles Schwab
California
$13.3K – – –
SG
36
StoneX Group
New York
$11K +$15K +2,054 New
BWP
37
Balboa Wealth Partners
Arizona
$6.4K – – –
LFAS
38
Level Four Advisory Services
Texas
$5.75K – – –
PI
39
PFG Investments
New York
$5.6K – – –
RPGK
40
Retirement Planning Group (Kansas)
Kansas
$5.56K – – –
PAG
41
Private Advisor Group
New Jersey
$5.34K – – –
CGA
42
Crescent Grove Advisors
Illinois
$5.34K – – –
DAS
43
Dynamic Advisor Solutions
Arizona
$5.34K – – –
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
$5K – – –
AA
45
Addison Advisors
Vermont
$2.78K – – –
TRCT
46
Tower Research Capital (TRC)
New York
$2.05K +$2.81K +384 New
SS
47
SBI Securities
Japan
$1.92K +$7 +1 +0.3%
Northwestern Mutual Wealth Management
48
Northwestern Mutual Wealth Management
Wisconsin
$801 – – –
Rockefeller Capital Management
49
Rockefeller Capital Management
New York
$534 – – –
Wells Fargo
50
Wells Fargo
California
$480 -$110 -15 -14%
1
2
3

IMUX Hedge Fund Activity: Q4 2025 in Review

58 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2025, worth a combined $28.3M — down 25% from $37.6M a quarter earlier.

Fund positioning in IMUX was balanced in Q4 2025: 9 funds opened new positions, 9 closed out, 17 added to existing stakes and 9 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.21M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $1.39M sold.

  • 58 institutional investors held Immunic (IMUX) as of Q4 2025, down from 59 in Q3 2025.
  • Funds reported $28.3M of Immunic stock for Q4 2025, down 25% quarter-over-quarter.
  • 9 funds opened new Immunic positions in Q4 2025 and 9 closed out, a net change of 0 holders.
  • The largest Immunic buyer in Q4 2025 was Nantahala Capital Management, an estimated $3.21M added.
  • The largest Immunic seller in Q4 2025 was Soleus Capital Management, an estimated $1.39M sold.

Based on aggregated 13F filings for Q4 2025.